Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT (Q3957989): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in nl: Adding Dutch translations) |
(Changed label, description and/or aliases in it: Adding Italian translations) |
||
| label / it | label / it | ||
Sviluppo di un nuovo radiofarmaco sierico ricombinante a base di albumina 99mTc e 68 radiofarmaco marcato con gas per i polmoni SPECT/CT e PET/CT | |||
Revision as of 21:41, 14 January 2022
Project Q3957989 in Hungary
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT |
Project Q3957989 in Hungary |
Statements
350,299,146 forint
0 references
2,017,586.097 Euro
0.0027336256 Euro
15 December 2021
0 references
738,062,336.185 forint
0 references
47.462349 percent
0 references
2 January 2018
0 references
31 December 2019
0 references
MEDI-RADIOPHARMA Egésszségügyi Szervező, Tanácsadó, Szolgáltató és Kereskedelmi Korlátolt Felelősségű Társaság
0 references
47°22'38.10"N, 18°55'16.97"E
0 references
Érd, Pest
0 references
Identifiers
VEKOP-2.1.1-15-2016-00082
0 references